glp-1 agonists ozempic New GLP-1; Semaglutide (Ozempic) GLP-1 Receptor Agonists' Impact on
Description
That's double the year prior
Your provider will guide the transition
According to data presented at the AASLD Liver Meeting in November 2024, semaglutide has shown significant efficacy in managing liver inflammation and fibrosis in a phase III clinical trial
doi: 10.1097/CM9.0000000000001712 [DOI] [PMC free article] [PubMed] [Google Scholar] 202
The response of different patients to GLP-1RAs may be different, and some patients may not be able to achieve the expected hypoglycemic effect
Lastly, concepts discussed within this review will be applied to a case scenario
